SEXUAL FUNCTION AFTER HYPOFRACTIONATED VERSUS CONVENTIONALLY FRACTIONATED RADIOTHERAPY FOR PROSTATE CANCER: RESULTS OF THE PROSPECTIVE, RANDOMIZED PHASE 3 HYPRO TRIAL

被引：1
|
作者：
Wortel, Ruud
Incrocci, Luca
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.321
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP47-02
引用
收藏
页码：E626 / E627
页数：2
相关论文
共 50 条
  • [41] Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature
    Francolini, G.
    Detti, B.
    Becherini, C.
    Caini, S.
    Ingrosso, G.
    Di Cataldo, Vanessa
    Stocchi, G.
    Salvestrini, V.
    Lancia, A.
    Scartoni, D.
    Giacomelli, I.
    Sardaro, A.
    Carbonara, R.
    Borghesi, S.
    Aristei, C.
    Livi, L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 165
  • [42] Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer: Early Toxicity Results from the Scandinavian Randomized Phase III Trial "HYPO-RT-PC"
    Widmark, A.
    Gunnlaugsson, A.
    Beckman, L.
    Thellenberg-Karlsson, C.
    Hoyer, M.
    Lagerlund, M.
    Fransson, P.
    Kindblom, J.
    Ginman, C.
    Johansson, B.
    Seke, M.
    Bjornlinger, K.
    Kjellen, E.
    Franzen, L.
    Nilsson, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (05): : 938 - 939
  • [43] Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir
    Anwar, Mekhail
    Weinberg, Vivian
    Chang, Albert J.
    Hsu, I-Chow
    Roach, Mack, III
    Gottschalk, Alexander
    RADIATION ONCOLOGY, 2014, 9
  • [44] Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir
    Mekhail Anwar
    Vivian Weinberg
    Albert J Chang
    I-Chow Hsu
    Mack Roach
    Alexander Gottschalk
    Radiation Oncology, 9
  • [45] Hypofractionated SBRT Versus Conventionally Fractionated EBRT for Prostate Cancer: Comparison of PSA Slope and Nadir
    Anwar, M.
    Weinberg, V.
    Chang, A.
    Hsu, I. J.
    Roach, M.
    Gottschalk, A. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S370 - S371
  • [46] Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer
    Hoffman, Karen E.
    Voong, K. Ranh
    Levy, Lawrence B.
    Allen, Pamela K.
    Choi, Seungtaek
    Schlembach, Pamela J.
    Lee, Andrew K.
    McGuire, Sean E.
    Quynh Nguyen
    Pugh, Thomas J.
    Frank, Steven J.
    Kudchadker, Rajat J.
    Du, Weiliang
    Kuban, Deborah A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (29) : 2943 - +
  • [47] Re: Ultra-Hypofractionated versus Conventionally Fractionated Radiotherapy for Prostate Cancer: 5-Year Outcomes of the HYPO-RT-PC Randomised, Non-Inferiority, Phase 3 Trial
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2020, 203 (01): : 32 - 32
  • [48] Moderately Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Prostate Cancer: A Comparative Study with Conventionally Fractionated Radiation
    Cante, Domenico
    Piva, Cristina
    Petrucci, Edoardo T. F.
    Sciacero, Piera
    Ferrario, Silvia
    Pasquino, Massimo
    Casanova Borca, Valeria
    La Porta, Maria R.
    Franco, Pierfrancesco
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [49] Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials
    Lehrer, Eric J.
    Kishan, Amar U.
    Yu, James B.
    Trifiletti, Daniel M.
    Showalter, Timothy N.
    Ellis, Rodney
    Zaorsky, Nicholas G.
    RADIOTHERAPY AND ONCOLOGY, 2020, 148 : 235 - 242
  • [50] Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
    Wilkins, Anna
    Mossop, Helen
    Syndikus, Isabel
    Khoo, Vincent
    Bloomfield, David
    Parker, Chris
    Logue, John
    Scrase, Christopher
    Patterson, Helen
    Birtle, Alison
    Staffurth, John
    Malik, Zafar
    Panades, Miguel
    Eswar, Chinnamani
    Graham, John
    Russell, Martin
    Kirkbride, Peter
    O'Sullivan, Joe M.
    Gao, Annie
    Cruickshank, Clare
    Griffin, Clare
    Dearnaley, David
    Hall, Emma
    LANCET ONCOLOGY, 2015, 16 (16): : 1605 - 1616
12345